UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000041690
Receipt No. R000047550
Scientific Title Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Date of disclosure of the study information 2020/09/05
Last modified on 2022/03/14 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Acronym Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Scientific Title Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Scientific Title:Acronym Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Region
Japan

Condition
Condition Healthy subjects
Classification by specialty
Rehabilitation medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine whether stimulation at a frequency of 100 Hz in peripheral electrical stimulation above the sensory threshold can increase the primary motor cortex's excitability earlier than at a frequency of 10 Hz.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Motor evoked potentials before stimulation, at 15, 30, 45, 60, 65, 70, and 75 minutes after stimulation
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Peripheral electrical stimulation

Frequency: 100 Hz
Intensity: above sensory threshold
Pulse width: 250 microsecond
Stimulation time: 60 minutes
Interventions/Control_2 Peripheral electrical stimulation

Frequency: 10 Hz
Intensity: above sensory threshold
Pulse width: 250 microsecond
Stimulation time: 60 minutes
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >=
Gender Male and Female
Key inclusion criteria 1) Age: from 20 to 60 years old
2) Obtaining agreement to this study
Key exclusion criteria 1) A history of orthopedic disease
2) A history of neurological diseases
3) Contraindicated to transcranial magnetic stimulation
4) Contraindications to peripheral electrical stimulation
5) Persons are deemed unsuitable by researchers or physicians
Target sample size 14

Research contact person
Name of lead principal investigator
1st name Daisuke
Middle name
Last name Kubo
Organization Tokai university hospital
Division name Department of rehabilitation services
Zip code 259-1193
Address 143 Shimokasuya, Isehara city, KANAGAWA
TEL 0463-93-1121
Email d.bokukubo@tokai.ac.jp

Public contact
Name of contact person
1st name Daisuke
Middle name
Last name Kubo
Organization Tokai university hospital
Division name Department of rehabilitation services
Zip code 259-1193
Address 143 Shimokasuya, Isehara city, KANAGAWA
TEL 0463-93-1121
Homepage URL
Email d.bokukubo@tokai.ac.jp

Sponsor
Institute Tokai university hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board for Clinical Research, Tokai University
Address 143 Shimokasuya, Isehara city, KANAGAWA
Tel 0463-93-1121
Email tokai-rinsho@ml.tokai-u.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 09 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 13
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 12 Month 10 Day
Date of IRB
2020 Year 02 Month 03 Day
Anticipated trial start date
2020 Year 02 Month 04 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 09 Month 04 Day
Last modified on
2022 Year 03 Month 14 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000047550